Use of Nonsteroidal Antiinflammatory Drugs

This publication has 45 references indexed in Scilit:

• Cyclooxygenase-2 Inhibition Increases Mortality, Enhances Left Ventricular Remodeling, and Impairs Systolic Function After Myocardial Infarction in the Pig
  Circulation, 2007
• What have we learnt from Vioxx?
  BMJ, 2007
• Cardiovascular Risk and Inhibition of Cyclooxygenase
  JAMA, 2006
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
  Circulation, 2006
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
  BMJ, 2006
• Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs?
  Thrombosis and Haemostasis, 2006
• Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
  Journal of Clinical Investigation, 2005
• Cyclooxygenase Inhibition and Cardiovascular Risk
  Circulation, 2005
• The Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  Circulation, 2005
• Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.
  Proceedings of the National Academy of Sciences, 1996